About CARDIOFLOW-B Company

We are a medical device company focusing on the development and commercialization of innovative transcatheter and surgical solutions in the field of structural heart disease. We are committed to providing doctors and patients with accessible, true, and beautiful medical solutions to treat structural heart disease. Our vision is to build a human-centered, world-leading emerging high-tech medical group. We are deeply involved in a large-scale, rapidly growing structural heart disease medical device market with a seriously inadequate penetration rate, and have a comprehensive structural heart disease product pipeline layout. We attach great importance to R&D and innovation, build a technological innovation system combining industry, education and research, deepen the field of structural heart disease with higher standards and better practices, and are committed to providing high-quality products and services to the global market. Our mission Our mission is to provide accessible, true, and beautiful healthcare solutions for structural heart disease. Our vision Our vision is to build a human-centered, world-leading emerging high-tech medical group. Product pipeline At present, the TAVI series products independently developed by the company have entered more than 500 hospitals in China, and successfully entered nearly 100 overseas hospitals in Argentina, Colombia, Thailand and Russia. The Anchorman left atrial occlusion device product independently developed by the subsidiary Shanghai Zuoxin has been approved by the NMPA for marketing. By introducing innovative therapies into the field of stroke prevention, a strategic pipeline layout in the field of structural heart disease and non-valvular heart disease has been achieved. Furthermore, through independent research and development and joint research and development with global partners, the company has established a comprehensive innovative research and development agency covering TAVI products, left ventricular occlusion products, TMV products, TTV products, and surgical support products. It is committed to building core product competitiveness and providing doctors and patients with true and beautiful medical solutions for the treatment of structural heart disease.